Bioavailability / Bioequivalence Services
Delivering audit-ready, protocol-driven oversight for global regulatory success
Bioequivalence Study Monitoring Services
Enabling Regulatory Confidence Through Precision Oversight
We deliver BE study monitoring aligned with global regulations (ICH-GCP, FDA, EMA, WHO, CDSCO) enabling inspection-ready data across geographies.
- Protocol Compliance Monitoring: SOP, 21 CFR, EU CTR 536/2014 alignment and real-time deviation management.
- Clinical Phase Oversight: Monitors trained in dosing, PK fidelity, informed consent & crossover designs.
- Risk-Based Site Monitoring: Facility, equipment, and cold chain inspections per FDA/EMA mandates.
- SDV & eCRF Validation: TransCelerate RBM methodology for GxP compliance.
- AE & Deviation Management: ICH E2A, MedDRA coded, CAPA-driven event tracking.
- Monitoring Deliverables: eCTD-ready reports, logs, and query resolution summaries.
Why Sponsors Choose SafeVig:
- GCP-certified early-phase clinical monitors
- Supports BE/BA, 505(b)(2), global bridging studies
- Lifecycle support from site to CSR
- Proven compliance with USFDA, ANSM, CDSCO
Bioavailability Study Monitoring Services
Advancing Regulatory Success Through Precision and Scientific Integrity
We offer BA study monitoring aligned with ICH-GCP, FDA, EMA, CDSCO, TGA, and Health Canada to enable reproducible, regulatory-accepted data.
- Compliance Oversight: Aligned with ICH E6(R2), 21 CFR Parts 50 & 56, EU 2001/20/EC. Ensures criteria adherence and informed consent documentation.
- PK Sampling Oversight: Predefined logs, matrix-specific timing, real-time supervision.
- Sample Chain of Custody: GLP, audit trails, validated bioanalytical logistics.
- Source Document Review: 100% SDV + RBM hybrid verification with traceability.
- AE Management: Integrated CAPA, ICH E2A, real-time escalation framework.
- Monitoring Output: Visit reports, site metrics, reconciled data logs, eCTD-ready.
Why SafeVig for BA:
- Expert PK monitors for SD/MD, fed/fasted, special populations
- eTMF, eCRF, RBM dashboards for efficient oversight
- Centers in LATAM, Southeast Asia, India, EU
- Supports small molecules, MR, 505(b)(2), nutraceuticals